Dr. Usiskin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Family Health Center
100 South Street
Morristown, NJ 07960Phone+1 973-889-6800
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1984 - 1987
- Rutgers Robert Wood Johnson Medical SchoolClass of 1984
Certifications & Licensure
- NJ State Medical License 1989 - 2023
Clinical Trials
- A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease Start of enrollment: 2016 Jul 25
- Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease Start of enrollment: 2016 Apr 04
Publications & Presentations
PubMed
- 12 citationsArtificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials.Harris A Ahmad, James E East, Remo Panaccione, Simon Travis, James B Canavan
Journal of Crohn's & Colitis. 2023-08-21 - 52 citationsLong-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHST...William J. Sandborn, Brian G. Feagan, Stephen B. Hanauer, Severine Vermeire, Subrata Ghosh
Journal of Crohn's & Colitis. 2021-07-05 - 53 citationsEffects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s DiseaseBrian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Xiaobin Li, Keith Usiskin
Gastroenterology. 2018-01-01
Press Mentions
- A Closer Look at Mucosal Healing in Ulcerative ColitisFebruary 14th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: